trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Chromosome Inversion D007446 1 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Visceral Pain D059265 1 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Sar P et al. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements. 2011 PLoS ONE pmid:21687737
Cosner CC and Helquist P Concise, convergent syntheses of (±)-trichostatin A utilizing a Pd-catalyzed ketone enolate α-alkenylation reaction. 2011 Org. Lett. pmid:21688856
Jang ER et al. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines. 2011 Mol. Cell. Biochem. pmid:21380726
Zhang FQ et al. Cell-cycle-dependent variations in the FTIR spectroscopy of HeLa cells treated with trichostatin A. 2011 Guang Pu Xue Yu Guang Pu Fen Xi pmid:22007388
Maruoka H et al. Low-molecular-weight compounds having neurotrophic activity in cultured PC12 cells and neurons. 2011 J. Biochem. pmid:21908547
Salvi V et al. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 2010 Sep-Oct Immunobiology pmid:20573419
Wang XH et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. 2010 Am. J. Pathol. pmid:20581057
Terhune SS et al. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. 2010 PLoS Pathog. pmid:20585571
Luo W et al. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. 2010 Cancer Res. pmid:20587525
Zaman MS et al. The functional significance of microRNA-145 in prostate cancer. 2010 Br. J. Cancer pmid:20588276
Shu ST et al. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. 2010 Anticancer Res. pmid:20651337
Paddock MN et al. The BRCT domain of PARP-1 is required for immunoglobulin gene conversion. 2010 PLoS Biol. pmid:20652015
Mossman D et al. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. 2010 BMC Cancer pmid:20618997
Ma J et al. Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. 2010 Carcinogenesis pmid:20622005
Oliveira CS et al. Effects of histone hyperacetylation on the preimplantation development of male and female bovine embryos. 2010 Reprod. Fertil. Dev. pmid:20591338
Suo L et al. Changes in acetylation on lysine 12 of histone H4 (acH4K12) of murine oocytes during maternal aging may affect fertilization and subsequent embryo development. 2010 Fertil. Steril. pmid:19285668
Xia J et al. Epigenetic modification of vomeronasal (V2r) precursor neurons by histone deacetylation. 2010 Neuroscience pmid:20594945
Tian F et al. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. 2010 Ann. N. Y. Acad. Sci. pmid:20633124
Rössler R et al. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. 2010 Neuroscience pmid:20643196
Rahman R et al. Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells. 2010 Mol. Cancer Ther. pmid:20643785
Tong JH et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. 2010 BMC Cancer pmid:20525238
Han DS et al. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways. 2010 J. Cell. Biochem. pmid:20568119
Bui HT et al. Effect of trichostatin A on chromatin remodeling, histone modifications, DNA replication, and transcriptional activity in cloned mouse embryos. 2010 Biol. Reprod. pmid:20505166
Kim IA et al. HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? 2010 J. Radiat. Res. pmid:20505264
Chen J et al. Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. 2010 Epigenetics pmid:20505343
Liu YW et al. Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells. 2010 J. Cell. Biochem. pmid:20506344
Kitamoto S et al. Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. 2010 Biochem. Biophys. Res. Commun. pmid:20510874
Liang Q et al. The novel human endogenous retrovirus-related gene, psiTPTE22-HERV, is silenced by DNA methylation in cancers. 2010 Int. J. Cancer pmid:20112338
Beedanagari SR et al. Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines. 2010 Toxicol. Lett. pmid:20116417
Lu Y et al. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. 2010 Hum. Reprod. pmid:20118114
Davies GF et al. Troglitazone inhibits histone deacetylase activity in breast cancer cells. 2010 Cancer Lett. pmid:19699029
Hajji N et al. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide. 2010 Oncogene pmid:20118981
Suh HS et al. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. 2010 J Neuroimmune Pharmacol pmid:20157787
Crosson CE et al. Inhibition of histone deacetylase protects the retina from ischemic injury. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20164449
Jang ER et al. ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response. 2010 Exp. Mol. Med. pmid:20164679
Desai D et al. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. 2010 Bioorg. Med. Chem. Lett. pmid:20167479
Ishimaru N et al. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. 2010 Biochem. Biophys. Res. Commun. pmid:20188708
Martinez-Diaz MA et al. Pre- and postimplantation development of swine-cloned embryos derived from fibroblasts and bone marrow cells after inhibition of histone deacetylases. 2010 Cell Reprogram pmid:20132016
Yang F et al. Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. 2010 BMC Plant Biol. pmid:20718950
Host L et al. Inhibition of histone deacetylases in rats self-administering cocaine regulates lissencephaly gene-1 and reelin gene expression, as revealed by microarray technique. 2010 J. Neurochem. pmid:20132486
Wu Y et al. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. 2010 BMC Cancer pmid:20132554
Kim TH et al. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice. 2010 Int. Immunopharmacol. pmid:20728595
Aoyama M et al. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. 2010 Nutrition pmid:20004081
Ji P et al. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. 2010 Haematologica pmid:20823130
Nunes MJ et al. Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription. 2010 J. Neurochem. pmid:20096088
Weng YI et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. 2010 Toxicol. Appl. Pharmacol. pmid:20678512
Aizawa S and Yamamuro Y Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells. 2010 Neurochem. Int. pmid:20100532
Tamannai M et al. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. 2010 Oncol. Res. pmid:20681406
Wu J et al. Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase. 2010 Acta Pharmacol. Sin. pmid:20048748
Sonnemann J et al. Serine proteases in histone deacetylase inhibitor-induced apoptosis. 2010 Mol. Cancer Ther. pmid:20682651
Hebbel RP et al. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. 2010 Blood pmid:20053759
Fu J et al. Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. 2010 Bioorg. Med. Chem. pmid:21067930
He R et al. Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents. 2010 J. Med. Chem. pmid:20055418
Nicodeme E et al. Suppression of inflammation by a synthetic histone mimic. 2010 Nature pmid:21068722
Ajiro K et al. Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivo. 2010 Cell Death Differ. pmid:20057502
Auzzas L et al. Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity. 2010 J. Med. Chem. pmid:21073160
Choi YS et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. 2010 J. Cell. Mol. Med. pmid:20070436
Lee KJ et al. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. 2010 Biochim. Biophys. Acta pmid:20080132
Grabiec AM et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. 2010 J. Immunol. pmid:20100935
Chatterjee A et al. An efficient synthesis of (+/-)-trichostatic Acid and analogues: a new route to (+/-)-trichostatin A. 2010 Org. Lett. pmid:20104892
Xu J et al. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. 2010 Breast Cancer Res. Treat. pmid:19466541
Li Y et al. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. 2010 Mol. Cancer pmid:20946668
Gupta PK et al. Inhibitors selective for HDAC6 in enzymes and cells. 2010 Bioorg. Med. Chem. Lett. pmid:20947351
Watson JA et al. Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. 2010 J. Cell. Mol. Med. pmid:19583812
Song S et al. Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. 2010 Cardiovasc. Res. pmid:19633316
Eskeland R et al. Histone acetylation and the maintenance of chromatin compaction by Polycomb repressive complexes. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21502416
McKenzie L et al. p53-dependent repression of polo-like kinase-1 (PLK1). 2010 Cell Cycle pmid:20962589
Mittal MK et al. Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. 2010 Mol. Biol. Rep. pmid:19277896
Zein S et al. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line. 2010 Exp. Biol. Med. (Maywood) pmid:20975082
Chao KC et al. Anti-tumor activity of histone deacetylase inhibitors and the effect on ATP-binding cassette in ovarian carcinoma cells. 2010 Eur. J. Gynaecol. Oncol. pmid:20882882
Lee CS et al. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines. 2010 Eur. J. Pharmacol. pmid:20868669
Yuan GB et al. Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells. 2010 Chin J Cancer pmid:20346212
Wang QH et al. Opposite effects of Trichostatin A on activation of mast cells by different stimulants. 2010 FEBS Lett. pmid:20371366
Simboeck E et al. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. 2010 J. Biol. Chem. pmid:20952396
Robertson DM et al. C-terminal cleavage of DeltaNp63alpha is associated with TSA-induced apoptosis in immortalized corneal epithelial cells. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20375332
Halili MA et al. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. 2010 J. Leukoc. Biol. pmid:20200406
Karagiannis TC et al. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. 2010 Aging (Albany NY) pmid:20930262
Reichrath S et al. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. 2010 J. Steroid Biochem. Mol. Biol. pmid:20206691
Milagre I et al. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 2010 J. Alzheimers Dis. pmid:20930312
Bertrand P Inside HDAC with HDAC inhibitors. 2010 Eur J Med Chem pmid:20223566
Gao A et al. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. 2010 Toxicol. Lett. pmid:20230882
Majid S et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. 2010 Cancer Res. pmid:20332239
Marumo T et al. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. 2010 Am. J. Physiol. Renal Physiol. pmid:19906951
Yakovlev A et al. Epigenetic regulation of caspase-3 gene expression in rat brain development. 2010 Gene pmid:19909801
Freidkin I et al. Effects of histone deacetylase inhibitors on rat mesangial cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19923417
Perisic T et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. 2010 Neuropsychopharmacology pmid:19924110
Kitano A et al. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. 2010 Mol. Vis. pmid:21203344
Sponziello M et al. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. 2010 J. Endocrinol. Invest. pmid:19794300
Himaki T et al. Effects of trichostatin A on in vitro development and transgene function in somatic cell nuclear transfer embryos derived from transgenic Clawn miniature pig cells. 2010 Anim. Sci. J. pmid:20887307
Wu P et al. Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. 2010 Cell Death Differ. pmid:19798105
Peidis P et al. HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2. 2010 Aging (Albany NY) pmid:21076179
Di Renzo F et al. VPA-related axial skeletal defects and apoptosis: a proposed event cascade. 2010 Reprod. Toxicol. pmid:19850124
Patil V et al. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. 2010 Bioorg. Med. Chem. pmid:19914074
Li X et al. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. 2010 Br. J. Haematol. pmid:19807731
Ninios YP et al. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A. 2010 Leuk. Res. pmid:19782399
Higashiyama R et al. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. 2010 Mod Rheumatol pmid:19784544
Law AY and Wong CK Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. 2010 Exp. Cell Res. pmid:19786016
Estiu G et al. On the inhibition of histone deacetylase 8. 2010 Bioorg. Med. Chem. pmid:20472442
Kobori A et al. Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines. 2010 World J. Gastroenterol. pmid:20480520
Kiyokawa S et al. New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. 2010 Bioorg. Med. Chem. pmid:20452226